India licenses generic copy of patented Bayer cancer drug March 17, 2012 By Northwest Asian Weekly By Katy Daigle The Associated Press NEW DELHI (AP) — India effectively ended Bayer’s monopoly on a patented cancer drug last Monday, licensing a much cheaper generic under a unique […]
